Drug–surfactant–propellant interactions in HFA-formulations
- 1 September 1999
- journal article
- review article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 186 (1) , 13-30
- https://doi.org/10.1016/s0378-5173(99)00134-9
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Surfactant Dissolution and Water Solubilization in Chlorine-Free Liquified Gas PropellantsDrug Development and Industrial Pharmacy, 1998
- Drug Form Selection in Albuterol-Containing Metered-Dose Inhaler Formulations and Its Impact on Chemical and Physical StabilityJournal of Pharmaceutical Sciences, 1997
- Micronizing of steroids for pulmonary delivery by supercritical carbon dioxideInternational Journal of Pharmaceutics, 1997
- Metered-dose inhalers I: drug content and particle size distribution of beclomethasone dipropionateJournal of Pharmaceutical and Biomedical Analysis, 1996
- The quantitative determination of aspirin and its degradation products in a model solution aerosolJournal of Pharmaceutical and Biomedical Analysis, 1995
- Surfactant promoted crystal growth of micronized methylprednisolone in trichloromonofluoromethaneInternational Journal of Pharmaceutics, 1994
- Scattering studies of microemulsions in low-density alkanesJournal of the Chemical Society, Faraday Transactions, 1990
- Effects of surfactants on aerosol powders in suspension. Implications for airborne particle sizeInternational Journal of Pharmaceutics, 1988
- Development of a systematic theory of suspension inhalation aerosols. II. Aggregates of monodisperse particles nebulized in polydisperse dropletsInternational Journal of Pharmaceutics, 1988
- Influence of Formulation on Aerosol Particle SizeJournal of Pharmaceutical Sciences, 1969